Back to News
research

Devyser Diagnostics AB (publ) (DVYSF) Q1 2026 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Devyser Diagnostics reported its fourth consecutive quarter of positive EBIT in Q1 2026, achieving 24% fixed-currency revenue growth and outperforming market expansion. Gross margins reached 82%, surpassing full-year 2025 levels, driven by cost-of-goods improvements and operational efficiency gains. The company secured multiple orders from Thermo Fisher, signaling progress toward stabilizing its order patterns and reducing volatility in revenue streams. CEO Jan Wahlstrom emphasized the shift toward profitable growth, a strategy initiated in early 2025, now yielding consistent financial gains and market share expansion. CFO Sabina Berlin highlighted sustained commercial momentum, with Q1 results reinforcing Devyser’s focus on high-margin diagnostics and long-term profitability.
AI Audio Summary
0:00 / 0:00
Click to play
Devyser Diagnostics AB (publ) (DVYSF) Q1 2026 Earnings Call Transcript

Summarize this article with:

SA Transcripts159.46K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Devyser Diagnostics AB (publ) (DVYSF) Q1 2026 Earnings Call April 27, 2026 5:00 AM EDT Company Participants Jan Wahlstrom - Chief Executive OfficerSabina Berlin - Chief Financial Officer Conference Call Participants Ulrik Trattner - DNB Carnegie, Research DivisionFilip Wiberg - Pareto Securities AS, Research DivisionLudvig Lundgren - Nordea Markets, Research Division Presentation Operator Welcome to Devyser Diagnostics Q1 Report 2026 presentation. [Operator Instructions] Now I will hand the conference over to the speakers. CEO, Jan Wahlstrom; and CFO, Sabina Berlin. Please go ahead. Jan WahlstromChief Executive Officer Good morning, and welcome to the Devyser Q1 2026 Earnings Call. My name is Jan Wahlstrom. I'm the CEO of Devyser and would like to thank you, everyone, for joining our call today. On the call today, we have, in addition to myself, also our CFO, Sabina Berlin. I will start with a short summary of highlights from the quarter before handing over to Sabina for a more detailed review of our financial results for January to March, and then we'll go through an update on our recent commercial activities. First quarter came in with a positive EBIT, the fourth consecutive quarter in a row. As you know, we started the journey in the beginning of last year, focusing the company towards profitable growth. It's been a successful journey, and we're happy to deliver a strong growth and positive EBIT. In the first quarter of the year, we continue to grow faster than the market. We grew 24% in fixed currencies. We received quite a few orders from Thermo in this quarter, a step towards a more stable order pattern. We're also very pleased with the gross margin of 82%. It's better than full year 2025, and we will continue to work on improving cost of goods sold. EBIT came in on a

Read Original

Tags

quantum-algorithms

Source Information

Source: Seeking Alpha